AstraZeneca plc (AZN.L)
AstraZeneca plc, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Andexxa/Ondexxya, Atacand, Atacand HCT, Atacand Plus, Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, Xigduo/Xigduo, and Zestril XR for cardiovascular, renal, and metabolism diseases; Accolate, Accoleit, Vanticon, Bevespi Aerosphere, Breztri Aerosphere, Bricanyl Respules and Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Rhinocort, Saphnelo, Symbicort, and Tezspire for respiratory and immunology; and Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. Its marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; and Personalis, Inc, as well as research collaboration with Sernova Corp. to evaluate novel potential therapeutic cell applications. The company was formerly known as Zeneca Group plc and changed its name to AstraZeneca plc in April 1999. AstraZeneca plc was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
Company Info
ISIN | GB0009895292 |
---|---|
Sector | Healthcare |
Industry | Drug Manufacturers-General |
Highlights
Market Cap | £187.73B |
---|---|
EPS | £3.20 |
PE Ratio | 37.84 |
PEG Ratio | 0.89 |
Revenue (TTM) | £47.61B |
Gross Profit (TTM) | £35.73B |
EBITDA (TTM) | £15.80B |
Year Range | £9,314.90 - £12,488.00 |
Target Price | £130.25 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of £10,000 in AstraZeneca plc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
AstraZeneca plc had a return of 16.04% year-to-date (YTD) and 3.35% in the last 12 months. Over the past 10 years, AstraZeneca plc had an annualized return of 14.64%, outperforming the S&P 500 benchmark which had an annualized return of 10.99%.
Period | Return | Benchmark |
---|---|---|
Year-To-Date | 16.04% | 11.18% |
1 month | 11.49% | 5.60% |
6 months | 19.88% | 17.48% |
1 year | 3.35% | 26.33% |
5 years (annualized) | 18.46% | 13.16% |
10 years (annualized) | 14.64% | 10.99% |
Monthly Returns
The table below presents the monthly returns of AZN.L, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | -0.94% | -3.43% | 6.96% | 12.96% | 16.04% | ||||||||
2023 | -5.60% | 4.21% | 3.24% | 4.58% | -0.73% | -3.29% | -0.80% | -4.07% | 4.13% | -7.67% | -1.21% | 4.68% | -3.53% |
2022 | -0.70% | 6.85% | 11.84% | 5.49% | -2.19% | 3.31% | 0.41% | -1.15% | -6.58% | 3.12% | 8.89% | 0.47% | 32.32% |
2021 | 2.28% | -5.46% | 4.35% | 6.46% | 4.29% | 7.92% | -4.78% | 3.80% | 5.21% | 1.52% | -8.99% | 4.86% | 21.78% |
2020 | -2.41% | -6.64% | 6.21% | 15.33% | 3.10% | -1.85% | 1.29% | -1.44% | 1.40% | -8.17% | 0.50% | -6.16% | -0.99% |
2019 | -5.81% | 13.63% | -0.07% | -6.67% | 1.87% | 10.37% | 9.68% | 4.70% | -0.78% | 3.31% | -0.57% | 2.00% | 33.98% |
2018 | -4.58% | 0.50% | 2.52% | 4.24% | 7.11% | -3.90% | 11.65% | -0.05% | 2.90% | 0.45% | 2.12% | -3.99% | 19.31% |
2017 | -5.49% | 14.40% | 5.78% | -5.60% | 12.86% | -1.89% | -11.02% | 0.93% | 9.12% | 1.55% | -5.07% | 7.20% | 21.08% |
2016 | -2.79% | -5.59% | -4.98% | 0.65% | 2.55% | 10.90% | 13.01% | -1.44% | 1.94% | -8.31% | -9.56% | 6.94% | 0.50% |
2015 | 4.12% | -3.06% | 3.51% | -2.81% | -2.76% | -8.08% | 7.49% | -3.33% | 1.49% | -0.74% | 8.48% | 2.53% | 5.66% |
2014 | 7.95% | 8.95% | -5.08% | 20.31% | -8.16% | 1.33% | 0.09% | 6.49% | -2.75% | 2.30% | 5.21% | -4.70% | 32.90% |
2013 | 4.93% | 2.20% | 10.15% | 1.30% | 1.36% | -8.06% | 7.06% | -2.97% | 1.18% | 2.91% | 6.18% | 1.74% | 30.29% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of AZN.L is 45, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.
AZN.L (AstraZeneca plc)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for AstraZeneca plc (AZN.L) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
AstraZeneca plc granted a 0.02% dividend yield in the last twelve months. The annual payout for that period amounted to £2.28 per share.
Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Dividend | £2.28 | £2.35 | £2.22 | £2.02 | £2.16 | £2.19 | £2.02 | £2.19 | £2.00 | £1.83 | £1.70 | £1.80 |
Dividend yield | 0.02% | 0.02% | 0.02% | 0.02% | 0.03% | 0.03% | 0.03% | 0.04% | 0.05% | 0.04% | 0.04% | 0.05% |
Monthly Dividends
The table displays the monthly dividend distributions for AstraZeneca plc. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | £0.00 | £1.56 | £0.00 | £0.00 | £0.00 | £1.56 | |||||||
2023 | £0.00 | £1.63 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.72 | £0.00 | £0.00 | £0.00 | £0.00 | £2.35 |
2022 | £0.00 | £1.45 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.76 | £0.00 | £0.00 | £0.00 | £0.00 | £2.22 |
2021 | £0.00 | £1.37 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.65 | £0.00 | £0.00 | £0.00 | £0.00 | £2.02 |
2020 | £0.00 | £1.46 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.70 | £0.00 | £0.00 | £0.00 | £0.00 | £2.16 |
2019 | £0.00 | £1.47 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.72 | £0.00 | £0.00 | £0.00 | £0.00 | £2.19 |
2018 | £0.00 | £1.34 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.68 | £0.00 | £0.00 | £0.00 | £0.00 | £2.02 |
2017 | £0.00 | £1.50 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.69 | £0.00 | £0.00 | £0.00 | £0.00 | £2.19 |
2016 | £0.00 | £1.31 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.69 | £0.00 | £0.00 | £0.00 | £0.00 | £2.00 |
2015 | £0.00 | £1.25 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.58 | £0.00 | £0.00 | £0.00 | £0.00 | £1.83 |
2014 | £0.00 | £1.17 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.53 | £0.00 | £0.00 | £0.00 | £0.00 | £1.70 |
2013 | £1.21 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.59 | £0.00 | £0.00 | £0.00 | £0.00 | £1.80 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the AstraZeneca plc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the AstraZeneca plc was 49.99%, occurring on Sep 24, 2002. Recovery took 970 trading sessions.
The current AstraZeneca plc drawdown is 2.10%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-49.99% | Mar 4, 2002 | 141 | Sep 24, 2002 | 970 | Jul 26, 2006 | 1111 |
-47.15% | Oct 26, 2006 | 352 | Mar 17, 2008 | 512 | Mar 25, 2010 | 864 |
-36.21% | Apr 6, 1999 | 226 | Feb 24, 2000 | 85 | Jun 29, 2000 | 311 |
-32.22% | Apr 7, 1998 | 128 | Oct 8, 1998 | 59 | Jan 5, 1999 | 187 |
-25.07% | Jul 21, 2020 | 158 | Mar 3, 2021 | 153 | Oct 11, 2021 | 311 |
Volatility
Volatility Chart
The current AstraZeneca plc volatility is 6.57%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
TTM | |
---|---|
Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |